Clinical trial

Autologous Mesenchymal Stromal Cells for Multiple Sclerosis

NCT02495766

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2015-05-11

PhasePHASE1 / PHASE2

Study timeline

Study start (actual)2015-05-11Date precision: day

Registry last updated2020-01-21

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Relapsing-Remitting Multiple Sclerosisverified · MONDO: relapsing-remitting multiple sclerosis

Secondary Progressive Multiple Sclerosisverified · MONDO: secondary progressive multiple sclerosis

Interventions

XCEL-MC-ALPHADRUG

Sponsors & collaborators

Banc de Sang i Teixitslead sponsor

Hospital Universitari Vall d'Hebron Research Institutecollaborator

Mapped research locations

BarcelonaSpain1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02495766 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.